` Comparison: OCC vs CYTH - Alpha Spread

OCC
vs
CYTH

Over the past 12 months, OCC has outperformed CYTH, delivering a return of -44% compared to the CYTH's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
OCC
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

OCC Intrinsic Value
0.43 AUD
Overvaluation 55%
Intrinsic Value
Price
CYTH Intrinsic Value
167.45 USD
Undervaluation 41%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Orthocell Ltd
ASX:OCC
0.95 AUD
Cyclo Therapeutics Inc
NASDAQ:CYTH
99 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
OCC, CYTH

OCC
CYTH
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Orthocell Ltd
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
OCC, CYTH

OCC
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Orthocell Ltd
ASX:OCC
Cyclo Therapeutics Inc
NASDAQ:CYTH
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

OCC
70.2%
CYTH
91.2%

Operating Margin

OCC
-127.4%
CYTH
-2 834.1%

Net Margin

OCC
-92.8%
CYTH
-2 848.2%

FCF Margin

OCC
-98%
CYTH
-2 586.1%

ROE

OCC
-89.7%
CYTH
341.5%

ROA

OCC
-27.7%
CYTH
-457.1%

ROIC

OCC
-191.4%
CYTH
1 154.9%

ROCE

OCC
-46.9%
CYTH
340.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
OCC, CYTH

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OCC, CYTH

Loading
OCC
CYTH
Difference
www.alphaspread.com

Performance By Year
OCC, CYTH

Loading
OCC
CYTH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare OCC to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account